118th Congress · HOUSE BILLBILL

H.R. 1805 — Leo’s Law

“To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.”

Health

Introduced Mar 27, 2023

Last action Apr 7, 2023

Pipeline · Bill → Law

Step 1

Introduced

Mar 27, 2023

Step 2

Referred

Apr 7, 2023

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill extends by 180 days the relevant periods of market exclusivity for drugs for rare diseases or conditions (i.e., orphan drugs) for which applications were submitted during the COVID-19 emergency period.

Provisions · 2 sectionsIntroduced in House

Timeline · 3 actions

Apr 7, 2023

Referred to the Subcommittee on Health.

Mar 27, 2023

Introduced in House

Mar 27, 2023

Referred to the House Committee on Energy and Commerce.